Bio-Key Intl Inc (BKYI)
1.7750 +0.0950 (+5.65%) 12:54 ET [NASDAQ]
1.7500 x 100 1.8000 x 900
Realtime by (Cboe BZX)
1.7500 x 100 1.8000 x 900
Realtime 1.7500 +0.0700 (+4.17%) 09:29 ET
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 2,145 | 1,141 | 2,181 | 1,825 | 1,817 |
Cost of Goods | 465 | 262 | 300 | 1,921 | 1,477 |
Gross Profit | 1,680 | 879 | 1,882 | -96 | 341 |
Operating Expenses | 2,725 | 2,795 | 2,690 | 3,549 | 2,783 |
Operating Income | -580 | -1,654 | -509 | -2,724 | -1,966 |
Interest Expense | 99 | 9 | 1 | 59 | 46 |
Other Income | -60 | -4 | 0 | 133 | 173 |
Pre-tax Income | -739 | -1,667 | -510 | -2,650 | -1,838 |
Income Tax | N/A | N/A | N/A | -277 | 0 |
Net Income Continuous | -739 | -1,667 | -510 | -2,373 | -1,838 |
Net Income | $-739 | $-1,667 | $-510 | $-2,373 | $-1,838 |
EPS Basic Total Ops | -0.39 | -1.00 | -0.32 | -3.77 | -3.22 |
EPS Basic Continuous Ops | -0.39 | -1.00 | -0.32 | -3.77 | -3.22 |
EPS Diluted Total Ops | -0.39 | -1.00 | -0.32 | -3.77 | -3.22 |
EPS Diluted Continuous Ops | -0.39 | -1.00 | -0.32 | -3.77 | -3.22 |
EPS Diluted Before Non-Recurring Items | -0.39 | -1.00 | -0.32 | N/A | -1.44 |
EBITDA(a) | $-367 | $-1,513 | $-369 | $-2,505 | $-1,853 |